Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

Abroad (travel likely)RecruitingPHASE3

Conditions

Fibromyalgia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Clinical Research Site, Little Rock, Arkansas, United States

  • Clinical Research Site, Santa Ana, California, United States

  • Clinical Research Site, Cromwell, Connecticut, United States

  • Clinical Research Site, Jacksonville, Florida, United States

  • Clinical Research Site, Orlando, Florida, United States

  • Clinical Research Site, Tampa, Florida, United States

  • Clinical Research Site, Atlanta, Georgia, United States

  • Clinical Research Site, Overland Park, Kansas, United States

  • Clinical Research Site, Louisville, Kentucky, United States

  • Clinical Research Site, Prairieville, Louisiana, United States

  • Clinical Research Site, Springfield, Missouri, United States

  • Clinical Research Site, Town and Country, Missouri, United States

  • Clinical Research Site, Tulsa, Oklahoma, United States

  • Clinical Research Site, Charleston, South Carolina, United States

  • Clinical Research Site, Memphis, Tennessee, United States

  • Clinical Research Site, Prosper, Texas, United States